Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Measuring self-reported sexual function in men with prostate cancer

Penny S Brucker1, David Cella

  • 1Institute for Health Services Research and Policy Studies, Northwestern University, Chicago, Illinois 60611, USA.

Urology
|October 11, 2003
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repeated measures analysis of patient-reported outcomes in prostate cancer after abiraterone acetate.

The Journal of community and supportive oncology·2016
Same author

Using Linear Equating to Map PROMIS(®) Global Health Items and the PROMIS-29 V2.0 Profile Measure to the Health Utilities Index Mark 3.

PharmacoEconomics·2016
Same author

Health-related quality of life during bosutinib (SKI-606) therapy in patients with advanced chronic myeloid leukemia after imatinib failure.

Current medical research and opinion·2016
Same author

Using Patient-reported Outcomes to Compare Relative Burden of Cancer: EQ-5D and Functional Assessment of Cancer Therapy-General in Eleven Types of Cancer.

Clinical therapeutics·2016
Same author

Health-related quality of life in patients with neuroendocrine tumors: an investigation of treatment type, disease status, and symptom burden.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2016
Same author

Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinoma.

Cancer·2016